Multiple Myeloma

FOI REFERENCE: 24492    FOI DATE: 5^th November 2024    

Over the past 6 months, how many adult multiple myeloma [MM] patients have you treated? If you refer your multiple myeloma patients to another centre, please state which. 150

Of the multiple myeloma patients over the past 6 month, how many were treated with the following: 

Bortezomib [Velcade], Melphalan/Cyclophosphamide and prednisolone/dexamethasone (VMp or VCd) 5 Patients

Bortezomib, thalidomide and dexamethasone [VTD] 1 Patient

Daratamumab [Darzalex] with Lenalidomide [Revlimid] and dexamethasone   51 Patients

Daratumumab [Darzalex], Bortezomib [Velcade], thalidomide and dexamethasone (known as Dara-VTd) 32 Patients

Selinexor, Bortexomiv [Velcade] and dexamethasone 2 Patients

Carfilzomib [Kyprolis] and dexamethasone 9 Patients

Bortezomib [Velcade] monotherapy or with dexamethasone 2 Patients

Daratumumab [Darzalex], Bortezomib [Velcade] and dexamethasone (known as DVd or DBd) 1 Patient

Carfilzomib [Kyprolis], Lenalidomide [Revlmid] and dexamethasone 5 Patients

Belantamab Mafodotin [Blenrep] 4 Patients

Idecabtagene vicleucel [Abecma] 0 Patients

Isatuximab [Sarclisa], Pomalidomide [Imnovid] and dexamethasone (known as IsaPd) 6 Patients

Elranatamab   1 Patient

Daratumumab [Darzalex] monotherapy 33 Patients

Ixazomib [Ninlaro], Lenalidomide [Revlmid] and dexamethasone (known as IRd) 16 Patients

Lenalidomide [Revlimid] and dexamethasone

Lenalidomide [Revlmid] monotherapy   58 Patients

Pomalidomide [Imnovid] and dexamethasone 58 Patients

Selinexor and dexamethasone 1 Patient

Talquetamab   0 Patients

Teclistamab [Tecvayli] 0 Patients